| Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar? NI Al-Dewik, HM Morsi, MM Samara, RS Ghasoub, CC Gnanam, ... Clinical Medicine Insights: Oncology 10, CMO. S32822, 2016 | 46 | 2016 |
| A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients M Vezzalini, A Mafficini, L Tomasello, E Lorenzetto, E Moratti, Z Fiorini, ... Journal of hematology & oncology 10, 1-11, 2017 | 25 | 2017 |
| Incidence, risk factors, and outcomes of preterm and early term births: a population-based register study S Younes, M Samara, R Al-Jurf, G Nasrallah, S Al-Obaidly, H Salama, ... International journal of environmental research and public health 18 (11), 5865, 2021 | 21 | 2021 |
| Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar MA Ismail, M Samara, A Al Sayab, M Alsharshani, MA Yassin, ... Molecular Genetics & Genomic Medicine 8 (10), e1319, 2020 | 12 | 2020 |
| Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients MA Ismail, M Vezzalini, H Morsi, A Abujaber, A Al Sayab, K Siveen, ... Scientific Reports 11 (1), 8833, 2021 | 10 | 2021 |
| Novel molecular findings in protein tyrosine phosphatase receptor gamma (PTPRG) among chronic myelocytic leukemia (CML) patients studied by next generation sequencing (NGS): A … NI Al-Dewik, M Monne, M Araby, A Al Sayab, M Vezzalini, L Tomasello, ... Blood, The Journal of the American Society of Hematology 128 (22), 5427-5427, 2016 | 7 | 2016 |
| Gene expression landscape of chronic myeloid leukemia K562 cells overexpressing the tumor suppressor gene PTPRG G Lombardi, RV Latorre, A Mosca, D Calvanese, L Tomasello, C Boni, ... International Journal of Molecular Sciences 23 (17), 9899, 2022 | 5 | 2022 |
| Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors MA Ismail, GK Nasrallah, M Monne, A AlSayab, MA Yassin, G Varadharaj, ... Gene 813, 146101, 2022 | 5 | 2022 |
| Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies S Younes, MA Ismail, R Al-Jurf, A Ziyada, GK Nasrallah, PV Abdulrouf, ... Hematology 28 (1), 2196866, 2023 | 4 | 2023 |
| Prevalence, predictors, and outcomes of major congenital anomalies: a population-based register study N Al-Dewik, M Samara, S Younes, R Al-Jurf, G Nasrallah, S Al-Obaidly, ... Scientific Reports 13 (1), 2198, 2023 | 4 | 2023 |
| Studying Methylation Status of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in the State of Qatar M Ismail, M Vezzalini, A Al Sayab, M Monne, V Gupta, G Varadharaj, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 3 | 2018 |
| Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar D Al-Sharshani, D Velayutham, M Samara, R Gazal, AAH Zen, MA Ismail, ... Molecular genetics & genomic medicine, e2178, 2023 | 2 | 2023 |
| Expression profiling of micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs) in chronic myeloid leukemia (CML) patients in the state of Qatar NI Al-Dewik, S Elshami, N Nasser, M Alsharshani, M Araby, MA Yassin, ... Blood 130, 5243, 2017 | 2 | 2017 |
| Protein tyrosine phosphatase receptor gamma as potential therapeutic target for chronic myeloid leukemia patients MA Ismail, C Sorio, N Al-Dewik Cancer Control 29, 10732748221140201, 2022 | 1 | 2022 |
| Studying The Effect of Various Parameters on The Characteristics of The Dielectric and Metallic Photonic Crystals M Ismail, ZM Badawy, E Abdel-Rahman Arab Journal of Nuclear Sciences and Applications 48 (3), 75-85, 2015 | 1 | 2015 |
| Maternal and Neonatal Outcomes of Post-Bariatric Surgery: A Population-Based Study NI Al-Dewik, M Samara, A Mahmah, A Al-Dewik, S Abou Nahia, ... | | 2024 |
| Principal molecular pathways affected in autism spectrum disorder SN Younes, R Al-Jurf, S Hammuda, GK Nasrallah, H Zayed, ... Proteins Associated with Neurodevelopmental Disorders, 1-47, 2022 | | 2022 |
| Down-regulation of Protein Tyrosine Phosphatase Receptor Gamma (PTPRG) in Chronic Myeloid Leukemia Patients in The State of Qatar is Due to Aberrant DNA Methylation Mechanism M Ismail, M Samara, A Al Sayab, M Alsharshani, M Yassin, M Vezzalini, ... | | 2020 |
Dr. Nader Al-Dewik, PhDDirector of Translational and Precision Medicine Research, Principal Investigator at WWRCVerified email at hamad.qa
